Literature DB >> 9818172

Genetic control of cell differentiation in the skeleton.

P Ducy1, G Karsenty.   

Abstract

The mechanisms of cell differentiation in the skeleton are just beginning to be unraveled. In the past year classical gene expression studies, genetic manipulation in mice and human genetic approaches have led to the identification of Osf2/Cbfa1 as a major regulator of osteoblast differentiation. Important progress was also made in the understanding of the control of osteoclast differentiation through the identification of osteoprotegerin and its ligand. These studies, as well as others of chondrocyte differentiation, provide a better understanding of skeletogenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9818172     DOI: 10.1016/s0955-0674(98)80037-9

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  13 in total

Review 1.  Molecular nature of the vitamin D receptor and its role in regulation of gene expression.

Authors:  P W Jurutka; G K Whitfield; J C Hsieh; P D Thompson; C A Haussler; M R Haussler
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.

Authors:  Otgonchimeg Rentsendorj; Andrea Nagy; Ildikó Sinkó; Andreea Daraba; Endre Barta; Ibolya Kiss
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 4.  Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

Authors:  C Kappen; A Neubüser; R Balling; R Finnell
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-12

5.  The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.

Authors:  Min-Su Han; Hyo-Jin Kim; Hee-Jun Wee; Kyung-Eun Lim; Na-Rae Park; Suk-Chul Bae; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Je-Yong Choi
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

Review 6.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

7.  Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts.

Authors:  Mario Galindo; Rachel A Kahler; Nadiya M Teplyuk; Janet L Stein; Jane B Lian; Gary S Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Mol Histol       Date:  2007-09-21       Impact factor: 2.611

Review 8.  Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells.

Authors:  Yu Zhang; Dilaware Khan; Julia Delling; Edda Tobiasch
Journal:  ScientificWorldJournal       Date:  2012-03-12

Review 9.  Tissue engineering of bone: the reconstructive surgeon's point of view.

Authors:  U Kneser; D J Schaefer; E Polykandriotis; R E Horch
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis.

Authors:  Mahdieh Taghizadeh; Mehrdad Noruzinia
Journal:  Cell J       Date:  2016-12-21       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.